CMS Pub. 100-03, ch. 1, § 270.6

A. General

Infrared therapy devices are used to treat an area of the skin and adjacent subcutaneous tissues of

a patient with infrared therapy energy, using an array of juxtaposed infrared diodes affixed to a

flexible pad to retain skin contact. The devices can also produce local warming, though this may

be a secondary effect. The use of infrared therapy devices has been proposed for a variety of

disorders; including treatment of diabetic neuropathy, other peripheral neuropathy, skin ulcers

and wounds, and similar related conditions, including conditions such as pain arising form these

conditions. A wide variety of devices are currently available.

B. Nationally Covered Indications

N/A

C. Nationally Non-Covered Indications

Effective for services performed on and after October 24, 2006, the Centers for Medicare &

Medicaid Services has determined that there is sufficient evidence to conclude the use of infrared

therapy devices and any related accessories is not reasonable and necessary under section

1862(a)(1)(A) of the Social Security Act (the Act). The use of infrared and/or near-infrared light

and/or heat, including monochromatic infrared energy, is non-covered for the treatment,

including the symptoms such as pain arising form these conditions, of diabetic and/or non-diabetic peripheral sensory neuropathy, wounds and/or ulcers of the skin and/or subcutaneous

tissues.

D. Other

N/A

(This NCD was last reviewed November 2006)